Conatus Pharmaceuticals Inc. Gains 29.34%

Thu 14 May 20 at 05:30 PM
Conatus Pharmaceuticals Inc. Gains 29.34%

Conatus Pharmaceuticals Inc. (CNAT:NASDAQ) rocketted at $0.63, representing a gain of 29.3%. On Wed 13 May 20, CNAT:NASDAQ hit a New 2-Week High of $0.48. The stock got featured on our News Catalysts scanner on Sat 02 May 20 at 04:55 AM in the 'EARNINGS' category. From Wed 29 Apr 20, the stock recorded 60.00% Up Days and 45.45% Green Days

The stock spiked on Wed 06 May 20 at $0.54 with a volume of 5M+.

About Conatus Pharmaceuticals Inc. (CNAT:NASDAQ)

Conatus Pharmaceuticals Inc is a biotechnology company. It focuses on the development and commercialization of novel medicines to treat liver disease.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.